Territory Sales Executive



1,001-5,000 employees

AI-driven precision medicine through clinical and molecular data analysis

Data & Analytics
AI & Machine Learning

Senior, Expert

Remote in USA

Required Skills
  • B.S. in life science, biology, business, or marketing
  • 3+ years of direct account management experience in a molecular diagnostic setting
  • 5+ years of experience working with major cancer centers and clinics, oncology GPO’s, large health systems, IHDN’s, and large oncology practices
  • Demonstrated measurable revenue generation at either a diagnostic, pharmaceutical, or relevant biotechnology company
  • Drive strategic business expansion/collaboration opportunities with major U.S. cancer centers and clinics
  • Structure detailed strategic plans for gaining and retaining new and existing clients
  • Maximize client-bill contracting opportunities
  • Implement laboratory services agreements (LSA’s) with bill account institutions
  • Collaborate and coordinate with all sales positions to ensure successful attainment of company goals and objectives
  • Identify and develop partnering opportunities between prospective oncology clients and Tempus
  • Promote and drive compliance with new web-based molecular information tools for all clients
  • Continually analyze competitive landscape and environment within assigned accounts to determine trends and provide customer feedback to Tempus leadership
  • Monitor performance of sales to ensure objectives are met
  • Develop and implement a comprehensive business plan for the territory
  • Work effectively with individuals across multiple departments throughout Tempus
  • Embrace, embody, and represent the Tempus company culture at all times to external and internal constituents

Tempus Labs, Inc. is a leader in precision medicine, leveraging artificial intelligence to analyze vast clinical and molecular data, enabling physicians to deliver personalized, data-driven care. The company's advanced machine learning platform and unique solution sets facilitate the discovery, development, and delivery of optimized therapeutic options for patients. With a focus on extensive molecular profiling, Tempus has developed a robust pan-cancer tumor organoid platform and validated a liquid biopsy assay, demonstrating their commitment to transforming personalized patient care and their position at the forefront of the healthcare industry.

Company Stage

Series G

Total Funding



Chicago, Illinois



Growth & Insights

6 month growth


1 year growth


2 year growth